0001209191-19-013906.txt : 20190226 0001209191-19-013906.hdr.sgml : 20190226 20190226214344 ACCESSION NUMBER: 0001209191-19-013906 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190224 FILED AS OF DATE: 20190226 DATE AS OF CHANGE: 20190226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haasner Dirk CENTRAL INDEX KEY: 0001704660 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38085 FILM NUMBER: 19635646 MAIL ADDRESS: STREET 1: C/O OVID THERAPEUTICS INC. STREET 2: 1460 BROADWAY, SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-24 0 0001636651 Ovid Therapeutics Inc. OVID 0001704660 Haasner Dirk C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036 0 1 0 0 SVP, Global Regulatory Affairs Employee Stock Option (Right to Buy) 1.89 2019-02-24 4 A 0 75000 0.00 A 2029-02-23 Common Stock 75000 75000 D 25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. /s/ Danielle Mann for Dirk Haasner by POA 2019-02-26